Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent diagnostic modalities for bladder cancer.

J Sheinfeld1, C Cordon-Cardo, N H Bander

  • 1Memorial Sloan-Kettering Cancer Center, New York, New York.

Immunology Series
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Editorial Expression of Concern: Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays.

British journal of cancer·2024
Same author

Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.

Skin health and disease·2021
Same author

Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma.

Cell death and differentiation·2015
Same author

TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation.

Cell death and differentiation·2015
Same author

MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9.

British journal of cancer·2014

Advances in diagnostic tools like hybridoma technology and molecular biology enhance bladder cancer understanding and early detection. Further research aims to identify high-risk patients for better treatment strategies.

Area of Science:

  • Oncology
  • Biotechnology
  • Diagnostic Medicine

Background:

  • Bladder cancer diagnosis and risk stratification remain critical challenges.
  • Current diagnostic methods have limitations in predicting disease progression and treatment response.

Purpose of the Study:

  • To review recent advancements in diagnostic technologies for bladder cancer.
  • To explore the potential clinical applications of these novel tools in early diagnosis and risk assessment.

Main Methods:

  • Review of hybridoma technology, immunohistochemistry, cytopathology, cytogenetics, and molecular biology.
  • Analysis of their application in understanding bladder cancer biology and clinical utility.

Main Results:

  • These technologies have improved the understanding of bladder cancer biology.

Related Experiment Videos

  • Emerging clinical applications show promise for early disease diagnosis.

    • Conclusions:

    • Further refinement of these advanced tools could reliably identify patients with superficial bladder tumors at high risk for muscle-invasive disease.
    • These tools may also identify patients whose tumors are resistant to current chemotherapy regimens.